CBU
TWST icon

CIBC Bancorp USA’s Twist Bioscience TWST Stock Holding History

CIBC Bancorp USA’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.31M Buy
22,458
+1,377
+7% +$89.6K ﹤0.01% 927
2026
Q1 		$1M Buy
+21,081
New +$945K ﹤0.01% 1043

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

CIBC Bancorp USA's TWST Position: Q2 2026 in Review

CIBC Bancorp USA increased its Twist Bioscience (TWST) stake by 6.5% in Q2 2026, buying an estimated $89.6K and bringing the position to 22,458 shares worth $2.31M. The position accounts for ﹤0.01% of the portfolio, ranked #927.

CIBC Bancorp USA first reported a position in TWST in Q1 2026 and has held it in 2 quarters since. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • CIBC Bancorp USA held 22,458 shares of Twist Bioscience worth $2.31M as of Q2 2026.
  • CIBC Bancorp USA bought 1,377 Twist Bioscience shares in Q2 2026, an estimated $89.6K.
  • Twist Bioscience made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #927 holding.
  • CIBC Bancorp USA first reported a position in Twist Bioscience in Q1 2026 and has held it in 2 quarters since.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.